Low Hemoglobin is Associated with Worse Outcomes Via Larger Hematoma Volume in Intracerebral Hemorrhage Due to Systemic Disease
Overview
Affiliations
Whether hemoglobin is associated with outcomes of a specific subtype of intracerebral hemorrhage (ICH) is unknown. A total of 4643 patients with ICH from a multicenter cohort were included in the analysis (64.0% male; mean age [SD], 58.3 [15.2] year), of whom 1319 (28.4%) had anemia on admission. The unsupervised consensus cluster method was employed to classify the patients into three clusters. The patients of cluster 3 were characterized by a high frequency of anemia (85.3%) and mainly composed of patients of systemic disease ICH subtype (SD-ICH; 90.0%) according to the SMASH-U etiologies. In SD-ICH, a strong interaction effect was observed between anemia and 3-month death (adjusted odds ratio [aOR] 4.33, 95% confidence interval [CI] 1.60-11.9, = 0.004), and the hemoglobin levels were linearly associated with 3-month death (aOR 0.75, 95% CI 0.60-0.92; = 0.009), which was partially mediated by larger baseline hematoma volume (= 0.008). This study demonstrated a strong linear association between low hemoglobin levels and worse outcomes in SD-ICH, suggesting that hemoglobin-elevating therapy might be extensively needed in a specific subtype of ICH.
Saeedi E, Mashhadinejad M, Tavallaii A Childs Nerv Syst. 2024; 41(1):51.
PMID: 39680160 DOI: 10.1007/s00381-024-06714-z.
Jiang X, Zhou L, Sun Z, Xie B, Lin H, Gao X Mol Biomed. 2023; 4(1):43.
PMID: 38008847 PMC: 10678901. DOI: 10.1186/s43556-023-00159-7.
Zhang S, Shu Y, Chen Y, Liu X, Liu Y, Cheng Y MedComm (2020). 2022; 3(1):e96.
PMID: 35281786 PMC: 8906467. DOI: 10.1002/mco2.96.